Published in J Immunol on March 15, 1993
Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation. J Virol (2000) 1.38
Induction of the chemokines interleukin-8 and IP-10 by human immunodeficiency virus type 1 tat in astrocytes. J Virol (2000) 1.32
Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity. Proc Natl Acad Sci U S A (1994) 1.23
Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev (2002) 1.12
Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J Virol (1996) 1.10
Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc Natl Acad Sci U S A (1994) 1.06
Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J Virol (1996) 1.04
Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein. J Virol (2002) 1.03
Human immunodeficiency virus Tat induces functional unresponsiveness in T cells. J Virol (1995) 0.95
Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon. Nucleic Acids Res (2010) 0.94
Tat-neutralizing antibodies in vaccinated macaques. J Virol (2003) 0.94
An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy. Clin Exp Immunol (2001) 0.93
Viral modulation of T-cell receptor signaling. J Virol (2008) 0.93
T helper cell activation and human retroviral pathogenesis. Microbiol Rev (1996) 0.88
HIV-1 Tat mediates degradation of RON receptor tyrosine kinase, a regulator of inflammation. J Immunol (2008) 0.85
Potentiation of the immune response in HIV-1+ individuals. J Clin Invest (1996) 0.84
Altered cytokine expression in T lymphocytes from human immunodeficiency virus Tat transgenic mice. J Virol (1995) 0.83
Dipeptidyl peptidase IV on activated T cells as a target molecule for therapy of rheumatoid arthritis. Clin Exp Immunol (2003) 0.82
Novel Tat-encoding bicistronic human immunodeficiency virus type 1-based gene transfer vectors for high-level transgene expression. J Virol (2000) 0.81
Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15. Immunology (1997) 0.80
Restoration of immune response by a cationic amphiphilic drug (AY 9944) in vitro: a new approach To chemotherapy against human immunodeficiency virus type 1. Antimicrob Agents Chemother (1998) 0.79
Expression of ectopeptidases in scleroderma. Ann Rheum Dis (1995) 0.77
Human immunodeficiency virus type 2 produces a defect in CD3-gamma gene transcripts similar to that observed for human immunodeficiency virus type 1. J Virol (1999) 0.77
Proliferative capacity and cytokine production by cells of HIV-infected and uninfected adults with different helminth infection phenotypes in South Africa. BMC Infect Dis (2014) 0.75
HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation. MBio (2016) 0.75
Development of an Attenuated Tat Protein as a Highly-effective Agent to Specifically Activate HIV-1 Latency. Mol Ther (2016) 0.75
Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science (1998) 3.68
Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature (1991) 3.07
Association of antibiotic treatment-resistant Lyme arthritis with T cell responses to dominant epitopes of outer surface protein A of Borrelia burgdorferi. Arthritis Rheum (1999) 2.01
Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med (1990) 1.81
Solution structure of the origin DNA-binding domain of SV40 T-antigen. Nat Struct Biol (1996) 1.77
Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen. Immunity (2001) 1.75
Two monoclonal rat antibodies with specificity for the beta-chain variable region V beta 6 of the murine T-cell receptor. Proc Natl Acad Sci U S A (1988) 1.75
Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers. Proc Natl Acad Sci U S A (2000) 1.61
B cells are essential for murine mammary tumor virus transmission, but not for presentation of endogenous superantigens. J Exp Med (1994) 1.56
Mls-1 is encoded by the long terminal repeat open reading frame of the mouse mammary tumor provirus Mtv-7. Proc Natl Acad Sci U S A (1992) 1.37
IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J Immunol (1992) 1.37
T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol (1998) 1.35
15N NMR spectroscopy of hydrogen-bonding interactions in the active site of serine proteases: evidence for a moving histidine mechanism. Biochemistry (1986) 1.35
Inhibition of dipeptidyl aminopeptidase IV (DP-IV) by Xaa-boroPro dipeptides and use of these inhibitors to examine the role of DP-IV in T-cell function. Proc Natl Acad Sci U S A (1991) 1.29
Unusual 1H NMR chemical shifts support (His) C(epsilon) 1...O==C H-bond: proposal for reaction-driven ring flip mechanism in serine protease catalysis. Proc Natl Acad Sci U S A (2000) 1.24
Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity. Proc Natl Acad Sci U S A (1994) 1.23
Human T cells respond to mouse mammary tumor virus-encoded superantigen: V beta restriction and conserved evolutionary features. J Exp Med (1993) 1.21
An Epstein-Barr virus-associated superantigen. J Exp Med (1996) 1.17
A low-barrier hydrogen bond in the catalytic triad of serine proteases? Theory versus experiment. Science (1997) 1.16
CD26 antigen and HIV fusion? Science (1994) 1.15
A method for preparing analytically pure sodium dithionite. Dithionite quality and observed nitrogenase-specific activities. Biochim Biophys Acta (1991) 1.14
Molecular analysis of antigen recognition by insulin-specific T-cell hybridomas from B6 wild-type and bm12 mutant mice. Mol Cell Biol (1987) 1.11
Structure-activity relationships of boronic acid inhibitors of dipeptidyl peptidase IV. 1. Variation of the P2 position of Xaa-boroPro dipeptides. J Med Chem (1996) 1.10
Kinetic properties of the binding of alpha-lytic protease to peptide boronic acids. Biochemistry (1988) 1.09
B cell differentiation antigens as probes for functional B cell subsets. Immunol Rev (1982) 1.08
Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. J Biol Chem (1999) 1.07
A novel apoptotic pathway in quiescent lymphocytes identified by inhibition of a post-proline cleaving aminodipeptidase: a candidate target protease, quiescent cell proline dipeptidase. J Immunol (1999) 1.06
Crystal versus solution structures of enzymes: NMR spectroscopy of a crystalline serine protease. Science (1989) 1.06
Vitamin E-enhanced IL-2 production in old mice: naive but not memory T cells show increased cell division cycling and IL-2-producing capacity. J Immunol (2001) 1.05
Macrophages and T cells do not express Mlsa determinants. J Immunol (1989) 1.05
The xid gene controls Ia.W39-associated immune response gene function. J Exp Med (1981) 1.04
Selective decrease of CD26 expression in T cells from HIV-1-infected individuals. J Immunol (1992) 1.04
A class II gene conversion event defines an antigen-specific Ir gene epitope. J Exp Med (1984) 1.03
Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells. J Immunol (2001) 1.02
Transcriptional repression of the IL-2 gene in Th cells by ZEB. J Immunol (1998) 1.01
Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. J Autoimmun (2001) 1.01
Catalytic mechanism of serine proteases: reexamination of the pH dependence of the histidyl 1J13C2-H coupling constant in the catalytic triad of alpha-lytic protease. Proc Natl Acad Sci U S A (1981) 1.01
Confirmation of the assignment of the low-field proton resonance of serine proteases by using specifically nitrogen-15 labeled enzyme. Proc Natl Acad Sci U S A (1985) 1.00
Antigenic marker on a functional subpopulation of B cells, controlled by the I-A subregion of the H-2 complex. Proc Natl Acad Sci U S A (1979) 1.00
Mechanism of action of adenosylcobalamin: glycerol and other substrate analogues as substrates and inactivators for propanediol dehydratase--kinetics, stereospecificity, and mechanism. Biochemistry (1977) 1.00
IL-1 activates two separate signal transduction pathways in T helper type II cells. J Immunol (1990) 0.99
Recombinant adenovirus coexpressing covalent peptide/MHC class II complex and B7-1: in vitro and in vivo activation of myelin basic protein-specific T cells. J Immunol (2001) 0.99
Superinduction of IL-2 gene transcription in the presence of cycloheximide. J Immunol (1991) 0.98
IL-1 signal transduction pathways. I. Two functional IL-1 receptors are expressed in T cells. J Immunol (1991) 0.98
Effect of phosphorylation on hydrogen-bonding interactions of the active site histidine of the phosphocarrier protein HPr of the phosphoenolpyruvate-dependent phosphotransferase system determined by 15N NMR spectroscopy. Biochemistry (1990) 0.98
Immune recognition of insulin by H-2b mice: the mutation in the I-Ab beta gene of the B6.C-H-2bm12 mouse alters the self-I-A-restricted T cell repertoire. Eur J Immunol (1984) 0.97
Vesicular localization and characterization of a novel post-proline-cleaving aminodipeptidase, quiescent cell proline dipeptidase. J Immunol (2000) 0.96
Localization of spontaneously hyperactive B cells of NZB mice to a specific B cell subset. Proc Natl Acad Sci U S A (1979) 0.95
Involvement of dipeptidyl peptidase IV in an in vivo immune response. Clin Exp Immunol (1992) 0.94
Human endogenous retrovirus-K18 Env as a risk factor in multiple sclerosis. Mult Scler (2008) 0.94
Increased thermohaline stratification as a possible cause for an ocean anoxic event in the Cretaceous period. Nature (2001) 0.91
Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules. J Exp Med (1994) 0.91
Mls-1-like superantigen in the MA/MyJ mouse is encoded by a new mammary tumor provirus that is distinct from Mtv-7. J Exp Med (1992) 0.91
Lack of MMTV superantigen presentation in MHC class II-deficient mice. Cell Immunol (1996) 0.91
Measurement of NH bond lengths by fast magic-angle spinning solid-state NMR spectroscopy: a new method for the quantification of hydrogen bonds. J Am Chem Soc (2001) 0.90
IgA-specific prolyl endopeptidases: serine type. Methods Enzymol (1994) 0.90
Direct binding of the Mtv7 superantigen (Mls-1) to soluble MHC class II molecules. Immunity (1995) 0.90
High-resolution nitrogen-15 nuclear magnetic resonance studies of alpha-lytic protease in solid state. Direct comparison of enzyme structure in solution and in the solid state. Biochemistry (1984) 0.89
Interleukin-1 induces protein tyrosine phosphorylation in T cells. Eur J Immunol (1992) 0.89
Association of mouse mammary tumor virus superantigen with MHC class II during biosynthesis. J Immunol (2001) 0.88
Abnormal regulation of low density lipoprotein-sensitive events in a cholesterol transport mutant. J Biol Chem (1993) 0.88
11B NMR spectroscopy of peptide boronic acid inhibitor complexes of alpha-lytic protease. Direct evidence for tetrahedral boron in both boron-histidine and boron-serine adduct complexes. Biochemistry (1993) 0.88
Separation of L-Pro-DL-boroPro into its component diastereomers and kinetic analysis of their inhibition of dipeptidyl peptidase IV. A new method for the analysis of slow, tight-binding inhibition. Biochemistry (1993) 0.87
15N and 1H NMR spectroscopy of the catalytic histidine in chloromethyl ketone-inhibited complexes of serine proteases. Biochemistry (1996) 0.87
Homodimerization via a leucine zipper motif is required for enzymatic activity of quiescent cell proline dipeptidase. J Biol Chem (2000) 0.86
Karoushi--death by overwork in the immune system. J Immunol (1995) 0.86
Regulation of macrophage activation markers by IL-4 and IFN-gamma is subpopulation-specific. Cell Immunol (1991) 0.86
Production and characterization of an Mls-1-specific monoclonal antibody. J Exp Med (1993) 0.85
Minor lymphocyte stimulatory antigen-bearing stimulator cells require lipopolysaccharide activation to induce programmed cell death in T cell hybridomas. J Immunol (1992) 0.85
Shared promoter elements between a viral superantigen and the major histocompatibility complex class II-associated invariant chain. J Virol (1997) 0.85
Regulation of IL-4 lymphokine gene expression and cellular proliferation in murine T helper type II cells. Cell Regul (1990) 0.85
Potentiation of the immune response in HIV-1+ individuals. J Clin Invest (1996) 0.84
Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. J Immunol (1993) 0.84
NMR analysis of interactions of a phosphatidylinositol 3'-kinase SH2 domain with phosphotyrosine peptides reveals interdependence of major binding sites. Biochemistry (1996) 0.83
Production of IL-1 alpha by activated Th type 2 cells. Its role as an autocrine growth factor. J Immunol (1991) 0.83
Serotonin (5-hydroxytryptamine) glucuronidation in vitro: assay development, human liver microsome activities and species differences. Xenobiotica (2003) 0.83
Electron spin-echo studies of the composition of the paramagnetic intermediate formed during the deamination of propanolamine by ethanolamine ammonia-lyase, and AdoCbl-dependent enzyme. J Biol Chem (1986) 0.83
Crystal versus solution structure of enzymes: NMR spectroscopy of a peptide boronic acid-serine protease complex in the crystalline state. Proc Natl Acad Sci U S A (1989) 0.83
Cytokine rescue from glucocorticoid induced apoptosis in T cells is mediated through inhibition of IkappaBalpha. Mol Immunol (1997) 0.83
Role of Ia. W39 in the interaction of antigen-presenting cells with T and B lymphocytes. Eur J Immunol (1982) 0.83
Structural analysis of a new B-cell-differentiation antigen associated with products of the I-A subregion of the H-2 complex. Proc Natl Acad Sci U S A (1981) 0.83
Identification of serine and histidine adducts in complexes of trypsin and trypsinogen with peptide and nonpeptide boronic acid inhibitors by 1H NMR spectroscopy. Biochemistry (1992) 0.82
HCN, a triple-resonance NMR technique for selective observation of histidine and tryptophan side chains in 13C/15N-labeled proteins. J Magn Reson B (1996) 0.82
Aminodipeptidase inhibitor-induced cell death in quiescent lymphocytes: a review. Apoptosis (2000) 0.82
Mechanism of action of adenosylcobalamin: hydrogen transfer in the inactivation of diol dehydratase by glycerol. Biochemistry (1978) 0.82
A 13C-NMR study of the role of Asn-155 in stabilizing the oxyanion of a subtilisin tetrahedral adduct. Biochem J (1997) 0.81
Control of lymphokine expression in T helper 2 cells. Proc Natl Acad Sci U S A (1989) 0.81
Lyb3: a B cell surface antigen associated with triggering secretory differentiation. Immunol Rev (1982) 0.81
Regulation of interleukin 6 production in T helper cells. Int Immunol (1990) 0.81
Cellular and molecular aspects of Lyme arthritis. Cell Mol Life Sci (2000) 0.81
Ia.W39 expression correlates with a specific Ir function. J Immunol (1982) 0.80
Primary and secondary in situ antibody response: abnormal affinity maturation pattern in mice carrying the xid gene. Eur J Immunol (1981) 0.80
B-lymphocyte responses to trinitrophenyl-ficoll. II. Decreased splenic adherent cell function in mice expressing the xid gene. Cell Immunol (1982) 0.80
Interleukin-1 induces c-fos and c-jun gene expression in T helper type II cells through different signal transmission pathways. Eur J Immunol (1992) 0.80